TRexit: tackling delays in cancer diagnosis
‘TRexit’ is a national initiative that could see a move away from transrectal (TRUS) biopsy, requiring an anaesthetic, to performing transperineal biopsy under local anaesthetic.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.